89bio, Inc. Deferred Tax Assets, Gross
89bio, Inc. had Deferred Tax Assets, Gross of $215.10 million as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2025-02-27
- 2024-12-31: Deferred Tax Assets, Gross $215.10M.
- 2023-12-31: Deferred Tax Assets, Gross $108.94M.
- 2022-12-31: Deferred Tax Assets, Gross $76.30M.
- 2021-12-31: Deferred Tax Assets, Gross $42.27M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2024-12-31 | $215.10M 10-K · filed 2025-02-27 |
| 2023-12-31 | $108.94M 10-K · filed 2025-02-27 |
| 2022-12-31 | $76.30M 10-K · filed 2024-03-01 |
| 2021-12-31 | $42.27M 10-K · filed 2023-03-15 |
| 2020-12-31 | $22.00M 10-K · filed 2022-03-24 |
| 2019-12-31 | $10.02M 10-K · filed 2021-03-25 |
| 2018-12-31 | $3.52M 10-K · filed 2020-03-18 |